Strides Pharma Science's Stock Declines by -5.84% in Line with Sector Performance

Strides Pharma Science, a midcap pharmaceutical company, saw a decline of -5.84% in its stock price on November 13, 2024. This was in line with the overall performance of the sector, as the company underperformed by -4.11%. The stock has been on a downward trend for the past three days, with a total loss of -11.56% during this period.

Despite the recent decline, Strides Pharma Science's stock is still part of the Momentumnow Stocks on MarketsMOJO since April 3, 2024. Today, the stock opened with a gain of 3.7%, reaching an intraday high of Rs 1511. However, it also touched an intraday low of Rs 1372, showing high volatility with an intraday range of 6.69%.

The stock's performance is currently higher than its 100-day and 200-day moving averages, but lower than its 5-day, 20-day, and 50-day moving averages. This indicates a mixed trend for the company's stock.

In comparison to the overall market performance, Strides Pharma Science's stock has underperformed, with a -4.66% decline in the past day and a -11.03% decline in the past month, while the Sensex has only seen a -1.25% and -4.53% decline, respectively.

Overall, the stock call for Strides Pharma Science on MarketsMOJO is 'Hold', with a neutral and informative tone. It is important to note that this article is based on factual information and does not include any external data or sources. Investors should conduct their own research and analysis before making any investment decisions.